KODK Files 4 with SEC

Rhea-AI Filing Summary

Eastman Kodak Company Executive Chairman and CEO James V. Continenza reported multiple stock option exercises and related share withholdings on 12/19/2025. He exercised options to buy 1,150,000 and 981,707 shares of common stock at an exercise price of $3.03 per share. A total of 706,229 and 602,878 shares were withheld at a price of $8.33 per share to cover the option exercise price and tax withholding in a "net exercise," and he retained the remaining shares. Following these transactions, he directly beneficially owned 2,878,544 shares of common stock. He also reports holdings of restricted stock units that vest between 2026 and 2028, phantom stock representing 241,589 share-equivalent units, and additional stock options with exercise prices between $4.53 and $12 expiring on 02/19/2029.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CONTINENZA JAMES V

(Last) (First) (Middle)

C/O EASTMAN KODAK COMPANY

343 STATE STREET

(Street)

ROCHESTER NY 14650

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN KODAK CO [ KODK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.01	12/19/2025		M		1,150,000(1)	A	$3.03	3,205,944	D
Common Stock, par value $.01	12/19/2025		F		706,229(1)	D	$8.33	2,499,715	D
Common Stock, par value $.01	12/19/2025		M		981,707(1)	A	$3.03	3,481,422	D
Common Stock, par value $.01	12/19/2025		F		602,878(1)	D	$8.33	2,878,544	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$3.03	12/19/2025		M			1,150,000(1)	(2)	02/19/2026	Common Stock, par value $.01	1,150,000	$0	0	D
Stock Option (Right to Buy)	$3.03	12/19/2025		M			981,707(1)	(2)	02/19/2026	Common Stock, par value $.01	981,707	$0	0	D
Restricted Stock Units	$0(3)							(3)	(3)	Common stock, par value $.01	100,000		100,000	D
Restricted Stock Units	$0(4)							(4)	(4)	Common Stock, par value $.01	196,336		196,336	D
Restricted Stock Units	$0(5)							(5)	(5)	Common Stock, par value $.01	114,943		114,943	D
Restricted Stock Units	$0(6)							(6)	(6)	Common Stock, par value $.01	163,613		163,613	D
Phantom Stock	$0(7)							(7)	(7)	Common Stock, par value $.01	241,589		241,589	D
Stock Option (Right to Buy)	$4.53							(2)	02/19/2029	Common Stock, par value $.01	298,780		298,780	D
Stock Option (Right to Buy)	$6.03							(2)	02/19/2029	Common Stock, par value $.01	298,780		298,780	D
Stock Option (Right to Buy)	$12							(2)	02/19/2029	Common Stock, par value $.01	170,733		170,733	D
Stock Option (Right to Buy)	$4.53							(2)	02/19/2029	Common Stock, par value $.01	350,000		350,000	D
Stock Option (Right to Buy)	$6.03							(2)	02/19/2029	Common Stock, par value $.01	350,000		350,000	D
Stock Option (Right to Buy)	$12							(2)	02/19/2029	Common Stock, par value $.01	200,000		200,000	D

Explanation of Responses:

1. The reporting person exercised stock options and used a portion of the shares to pay the option exercise price and cover tax withholding obligations (a "net exercise") by electing to have the issuer withhold shares otherwise deliverable after the stock option exercise. The reporting person retained all of the remaining shares. The stock options were granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3, and were scheduled to expire on February 19, 2026. The reporting person exercised the stock options in a transaction exempt under Rule 16b-3 in accordance with a policy adopted by the Compensation, Governance and Nominating Committee of the Board of Directors allowing employees to net exercise stock options as long as the stock options are scheduled to expire within three months of the date of exercise.

2. This option is fully vested as of the date of this report.

3. These restricted stock units, which convert into common stock on a one-for-one basis ("RSUs"), will vest on 2/26/2026, except as otherwise provided in the award notice.

4. These RSUs will vest on 11/29/2026, except as otherwise provided in the award notice.

5. These RSUs will vest in substantially equal installments on each of 11/29/2026 and 11/29/2027, except as otherwise provided in the award notice.

6. These RSUs will vest in substantially equal installments on each of 11/29/2026, 11/29/2027 and 11/29/2028, except as otherwise provided in the award notice.

7. Each share of phantom stock represents a right to receive one share of common stock and becomes payable at the election of Mr. Continenza in the year following the year of his separation from service as a director in either a single lump sum payment or in a maximum of ten annual installments.

	/s/ Roger W. Byrd, Attorney-in-Fact for James V. Continenza	12/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.